企業プロフィール
Adagene 株価・ニュース・カタリスト
- ティッカー:
- ADAG
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- China and listed in the U
株価パフォーマンス
3.83 USD (+3.51%)
終値
最終更新: 2026年8月17日
224M USD
時価総額
株価変動の要因
As of Aug 17, 2026, ADAG closed up 3.51% at $3.83. No new same-company headline was identified in the current news window.
企業概要
事業概要
Adagene is a biotechnology company focused on next-generation antibody engineering and cancer immunotherapy. Its story is built around precision antibody design and the effort to create differentiated oncology medicines.
所在地とセクター分類
Adagene is headquartered in China and listed in the U.S. market. It sits in oncology biotechnology with a platform-engineering identity.
ビジネスモデルの特徴
The company depends on translational validation, clinical data, and the ability to turn antibody engineering into clinical value. Investors watch proof-of-concept, partnerships, and capital runway.
バイオ業界での位置付け
Adagene occupies a specialized antibody-engineering niche within biotech. It is catalyst-sensitive because the platform still needs to prove broad therapeutic differentiation.
今後のカタリスト
- Adagene’s catalysts are its immune-modulating antibody platform and any clinical or partnership update that shows the technology can still differentiate. The company still needs stronger human proof.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。